HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl F Hilgers Selected Research

Nephrosclerosis

1/2020Correlations Between Interleukin-11 Expression and Hypertensive Kidney Injury in a Rat Model of Renovascular Hypertension.
2/2009Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.
7/2008Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a.
3/2008(Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats.
7/2006Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
10/2003Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karl F Hilgers Research Topics

Disease

25Hypertension (High Blood Pressure)
01/2021 - 03/2002
11Fibrosis (Cirrhosis)
01/2020 - 03/2002
8Inflammation (Inflammations)
12/2019 - 09/2005
7Diabetic Nephropathies (Diabetic Nephropathy)
09/2017 - 01/2000
6Renovascular Hypertension (Goldblatt Syndrome)
12/2021 - 03/2003
6Nephrosclerosis
01/2020 - 10/2003
5Glomerulonephritis
10/2021 - 01/2003
5Atherosclerosis
01/2017 - 05/2010
4Malignant Hypertension
12/2021 - 11/2007
4Nephritis
01/2021 - 01/2003
4Albuminuria
06/2013 - 10/2003
3Proteinuria
11/2020 - 04/2014
3Chronic Renal Insufficiency
09/2017 - 04/2002
2Weight Loss (Weight Reduction)
01/2020 - 09/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2019 - 11/2008
2Diarrhea
09/2019 - 04/2010
2Neoplasms (Cancer)
09/2019 - 02/2016
2Ischemia
04/2017 - 01/2017
2Ureteral Obstruction
01/2016 - 01/2012
2Neointima
05/2015 - 10/2012
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2014 - 05/2005
2Renal Insufficiency (Renal Failure)
01/2014 - 03/2004
2Fetal Growth Retardation (Intrauterine Growth Retardation)
10/2012 - 01/2011
2Hyperplasia
11/2009 - 05/2009
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
08/2007 - 04/2007
2Marfan Syndrome (Marfan's Syndrome)
06/2006 - 10/2004
2Diabetes Mellitus
05/2005 - 01/2000
1Thrombotic Microangiopathies
12/2021
1Sclerosis
12/2020
1Necrosis
01/2020
1Coronary Disease (Coronary Heart Disease)
12/2019
1Tuberculosis (Tuberculoses)
09/2019
1Pain (Aches)
09/2019
1Vascular Calcification
03/2017
1Body Weight (Weight, Body)
01/2017
1Atherosclerotic Plaque (Atheroma)
05/2015
1Acute Kidney Injury (Acute Renal Failure)
10/2014

Drug/Important Bio-Agent (IBA)

13SaltsIBA
05/2009 - 03/2002
9IntegrinsIBA
01/2017 - 03/2002
8Desoxycorticosterone Acetate (DOCA)FDA Link
02/2009 - 03/2002
7ReninIBA
01/2016 - 03/2003
5Apolipoproteins E (ApoE)IBA
01/2017 - 05/2010
5Acetates (Acetic Acid Esters)FDA Link
01/2017 - 10/2003
5Streptozocin (Streptozotocin)FDA Link
04/2014 - 01/2000
5Desoxycorticosterone (Deoxycorticosterone)IBA
02/2009 - 03/2002
4Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2003
4Nitric Oxide Synthase (NO Synthase)IBA
03/2014 - 01/2000
4EnzymesIBA
03/2014 - 02/2008
4Angiotensin IIIBA
08/2011 - 06/2005
3salicylhydroxamic acid (SHAM)IBA
12/2021 - 10/2007
3Biomarkers (Surrogate Marker)IBA
01/2020 - 05/2010
3dimethylargininaseIBA
03/2014 - 02/2008
3N,N-dimethylarginine (asymmetric dimethylarginine)IBA
03/2014 - 02/2008
3Fibrillin-1IBA
01/2014 - 10/2004
3Angiotensin II Type 1 Receptor BlockersIBA
04/2007 - 09/2004
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2004 - 04/2002
2Complement System Proteins (Complement)IBA
12/2021 - 11/2008
2RNA (Ribonucleic Acid)IBA
12/2021 - 04/2017
2ChemokinesIBA
12/2020 - 11/2008
2AntibodiesIBA
12/2020 - 02/2016
2AcidsIBA
09/2019 - 04/2010
2Antihypertensive Agents (Antihypertensives)IBA
01/2018 - 11/2008
2CholesterolIBA
01/2017 - 01/2014
2AldosteroneIBA
01/2016 - 01/2008
2AdrenomedullinIBA
01/2010 - 09/2005
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2009 - 03/2004
2MineralocorticoidsIBA
11/2008 - 04/2007
2CollagenIBA
11/2008 - 02/2007
2AngiotensinogenIBA
11/2007 - 04/2007
2Angiotensin Receptor AntagonistsIBA
04/2007 - 09/2004
2AngiotensinsIBA
02/2007 - 05/2005
1Complement Inactivating AgentsIBA
12/2021
1Substance PIBA
01/2021
1Muscle Proteins (Muscle Protein)IBA
01/2021
1Capsaicin (Zostrix)FDA Link
12/2020
1Pharmaceutical PreparationsIBA
12/2020
1TachykininsIBA
12/2020
1Aprepitant (Emend)FDA Link
12/2020
1calcitonin gene-related peptide (8-37)IBA
11/2020
1Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
11/2020
1Interleukin-11 (Interleukin 11)IBA
01/2020
1Chemokine ReceptorsIBA
12/2019
1Coloring Agents (Dyes)IBA
03/2017
1calcium phosphateIBA
03/2017
1Carbon MonoxideIBA
01/2017
1Triglycerides (Triacylglycerol)IBA
01/2017
1PolyvinylsIBA
01/2016
1Scarlet Red (Sudan IV)IBA
05/2015
1IrbesartanFDA LinkGeneric
04/2014

Therapy/Procedure

7Surgical Instruments (Clip)
12/2021 - 03/2003
4Therapeutics
09/2019 - 11/2008
4Ligation
04/2017 - 10/2012
2Kidney Transplantation
09/2019 - 10/2014
2Injections
04/2014 - 05/2005
1Electrodes (Electrode)
12/2020
1Intravenous Injections
11/2020
1Renal Replacement Therapy (Therapies, Renal Replacement)
09/2017
1Glycemic Control
09/2017
1Nephrectomy
01/2017
1Transplantation
10/2013